Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Ethanol and Ceftriaxone

supplement:

Ethanol

Research Papers that Mention the Interaction

Disulfiram-like reactions are also related to the side chains associated with coagulation defects and have been reported when patients receiving cefoperazone, moxalactam, or ceftriaxone have ingested alcohol.
The American journal of medicine  •  1990  |  View Paper
Ceftriaxone promoted a significant reduction in brain sulfhydryl content in zebrafish subjected to EtOH withdrawal.
Ceftriaxone treatment resulted in increased glutamate uptake in zebrafish subjected to EtOH withdrawal.
Therefore, Cef treatment in conjunction with EtOH withdrawal induced anxiolytic-like effects due to possible neuromodulation of glutamatergic transporters, potentially through mitigation of oxidative stress.
Neurochemical Research  •  2020  |  View Paper
Ceftriaxone (CTX) restores xCT and GLT1 expression and effectively suppresses cocaine and ethanol reinstatement, however, the effects of CTX on amphetamine (AMP) reinstatement are not determined.
Brain Research  •  2019  |  View Paper
Ceftriaxone is known to increase the expression and/or activity of glutamate transporters in the brain and prevented both the decreases in glutamate aspartate transporter and the increases in basal extracellular glutamate when administered during EtOH drinking.
Journal of neurochemistry  •  2019  |  View Paper
Parenteral treatment with ceftriaxone , &bgr;‐lactam antibiotic, has been reported to attenuate ethanol consumption and reinstatement to cocaine‐seeking behavior, in part, by restoring the expression of GLT‐1 and xCT in mesocorticolimbic brain regions in rats.
Behavioural Brain Research  •  2017  |  View Paper
Studies from our laboratory showed that upregulation of glutamate transporter 1 (GLT-1) and cystine-glutamate exchanger (xCT) expression with ceftriaxone , β-lactam antibiotic, in the brain was associated with attenuation of ethanol consumption.
Neuroscience Letters  •  2017  |  View Paper
We have shown that administration of ceftriaxone (CEF), a β-lactam antibiotic, reduced EtOH intake and increased glutamate transporter 1 (GLT-1) expression in mesocorticolimbic regions of male and female alcohol-preferring (P) rats.
Neuroscience  •  2016  |  View Paper
Ceftriaxone treatment attenuated ethanol intake as well as ethanol preference.
Ceftriaxone treatment blocked the increase extracellular glutamate produced by ethanol intake.
Our present study demonstrates that ceftriaxone treatment prevents ethanol drinking in part through normalization of extracellular glutamate concentrations in NAc of male P rats via GLT-1.
Neuropharmacology  •  2015  |  View Paper
Ceftriaxone 100 mg/kg per injection twice per day (200 mg/kg/day) reduced or abolished all manifestations of ethanol withdrawal in both rat variants and prevented withdrawal-induced escalation of alcohol intake.
Finally, ceftriaxone treatment was associated with lasting upregulation of ethanol withdrawal-induced downregulation of EAAT2 in the striatum.
Neuropsychopharmacology  •  2014  |  View Paper
These findings demonstrated the effectiveness of ceftriaxone in attenuating ethanol intake in a chronic consumption paradigm.
We found that ceftriaxone treatment resulted in a significant reduction in ethanol intake starting from day 2 (48 h after the first i.p.
We have previously shown that ceftriaxone , a β-lactam antibiotic known to upregulate glutamate transporter 1 (GLT1), reduced ethanol intake after 5 weeks of free choice ethanol drinking paradigm in male alcohol-preferring (P) rats.
Journal of Molecular Neuroscience  •  2014  |  View Paper
Show More